taptap188(正版游戏)官方网站
Home
About Us
Company Culture
Milestones
Awards and Honors
Social Responsibility
Talent Development
Hot
Recombinant Protein Product
Research and Innovation
Research and Innovation
Main Pipelines
Product Category
Drug Products
Peginterferon Alfa-2b Injection
Pegsomatropin Injection
Pegfilgrastim Injection
Molgramostim
Filgrastim
Oprelvekin
API
Reagents
Growth Factors
Interleukins
Interferons
Enzymes
Others
News
Contact Us
English
简体中文
Home
/
News
News and Events
Amoytop Biotech Awarded National-level "Individual Champion Enterprise in Manufacturing Industry"
People's Daily Health Client Side: From Treatment to Cure —— China's Prevention and Control of Hepatitis B Has Entered a New Era of Functional Cure
Pegpesen(Pegsomatropin Injection) has approved for clinical trial of its new indication
A New Journey Begins: First National Batch Shipment of Pegpesen® (Pegsomatropin Injection)
1
2
3
4
...
11
»
Facebook
Twitter
LinkedIn
Instagram
WELCOME
Specialized in R&D and production of recombinant protein drugs, and committed to providing better solutions for viral hepatitis, malignant tumor and immunotherapy etc..
Fax: +86-592-6889110
international@amoytop.com
Tel: +86-592-6889106
Copyright ©
2023
Amoytop Biotech All Rights Reserved. Support by
Leadong
｜
Sitemap
.
Privacy Policy
Email
international@amoytop.com
reagent@amoytop.com
Tel
+86-592-6889106
cell Phone
+86-18060918257
Leave a Message
Get In Touch
Submit
